Related Experiment Video

Updated: Jan 7, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K

mRNA-Based Personalized Cancer Vaccines: Opportunities, Challenges and Outcomes

A A Ibragimova1, A A Fedorov1, K M Kirilenko2

  • 1Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, 634009 Russia.

Acta Naturae
|January 2, 2026
PubMed

Insights

Messenger RNA (mRNA) cancer vaccines activate the immune system against tumors using specific antigens. These adaptable therapeutics show promise for improving cancer treatment efficacy and patient survival.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Messenger RNA (mRNA) vaccines offer a novel strategy for cancer treatment by targeting tumor-specific antigens.
  • This approach activates the patient's immune system to recognize and attack cancer cells.

Purpose of the Study:

  • To review the development of manufacturing technologies for mRNA-based cancer therapeutics.
  • To describe the design algorithm for personalized anti-tumor mRNA vaccines.
  • To summarize current clinical trials and discuss practical implementation in cancer immunotherapy.

Main Methods:

  • Review of manufacturing technologies for mRNA therapeutics.
  • Description of an algorithm for designing personalized mRNA cancer vaccines.
  • Summary of ongoing clinical trials in cancer immunotherapy.

Main Results:

  • mRNA cancer vaccines are based on tumor antigens to stimulate an immune response.
  • Clinical trials are active for various cancers, including melanoma, lung, pancreatic, and breast cancer.
  • These vaccines demonstrate a favorable safety profile and adaptability.

Conclusions:

  • mRNA-based cancer vaccines hold significant promise for enhancing treatment efficacy and prolonging patient survival.
  • The adaptability and safety profile of mRNA therapeutics are key advantages.
  • Ongoing clinical trials are crucial for validating the potential of mRNA cancer vaccines in immunotherapy.
Keywords:
cancerclinical trialsimmunotherapyliposomesmRNA vaccineneoantigens

More Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.2K
Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.7K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
926
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
911
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K